Alnylam Pharmaceuticals, Inc. (ALNY)
300.58
+2.10
(+0.70%)
USD |
NASDAQ |
May 21, 16:00
302.00
+1.42
(+0.47%)
After-Hours: 19:59
Alnylam Pharmaceuticals Accounts Payable (Quarterly) : 126.63M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Aldeyra Therapeutics, Inc. | 0.1414M |
| Ionis Pharmaceuticals, Inc. | 26.03M |
| Gilead Sciences, Inc. | 645.00M |
| Regeneron Pharmaceuticals, Inc. | 1.027B |
| Sarepta Therapeutics, Inc. | 70.38M |